Table 2.
Stages | UK mode (min) | Japan mode (min) |
---|---|---|
4D-CT | 30–40 | |
Target and OAR delineation | 30–60 | |
Treatment planning | >91 | 61–120 |
Patient-specific plan QA | 30–45 | 50–60 |
Daily treatment delivery | 21–30 | 30 |
4D-CT, four-dimensional CT; OAR, organ at risk; QA, quality assurance.